Ali McBride, PharmD, MS, BCOP, discusses the theme for his presidency: Collaborate. Educate. Compensate: A Prescription for Sustainable Cancer Care Delivery.<br />
Ali McBride, PharmD, MS, BCOP, Association of Community Cancer Centers (ACCC) President and clinical coordinator of hematology/oncology at The University of Arizona Cancer Center, discusses the theme for his presidency: Collaborate. Educate. Compensate: A Prescription for Sustainable Cancer Care Delivery.
Compensation is the foundation of what he would like to address during his term, says McBride. He plans to develop layers of understanding of the cost of care for patients, which is often overlooked. ACCC will provide further support and understanding on these measures.
The second piece of this theme is innovation, an ongoing strategic goal across both cancer care and healthcare in general. ACCC will provide more educational resources in understanding new models, new techniques, and new electronic devices, McBride says.
SELECT Trial Establishes Lenvatinib’s Role in RAI-Refractory DTC
May 2nd 2024In an interview with Targeted Oncology, Lori J. Wirth, MD, delved into how the data from SELECT signals lenvatinib effectiveness as a frontline therapy for patients with RAI-refractory differentiated thyroid cancer.
Read More
Landgren on MRD as an End Point for Multiple Myeloma Trials
May 1st 2024C. Ola Landgren, MD, PhD, discussed the FDA’s unanimous ODAC vote supporting minimal residual disease as an accelerated approval end point in multiple myeloma and the implications of this vote in the myeloma research field.
Read More